Key topics New frontiers of pharmaceutical law Patent law issues related to new frontiers in pharmacogenomics: conditions of patentability in Europe and in the USA, best practice for agreements between university and industrySupplementary protection certificatesThe borderline between pharmaceutical products and medical devicesRevision of the EU legislation on medical devices and in vitro diagnosticsPersonalised medicinesData protection issues: bio-banking and data protection of biomarkers  Recent legislative developments The implementation of the new legislation on pharmacovigilance (Regulation 1235/2010 and Directive 2010/84) Adoption of Directive 2011/62 on the prevention of the entry into the legal supply chain of falsified medicinal products Update on recent developments